Palbociclib (Ibrance)
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Palbociclib (Ibrance), covering 2013-12-17 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database